Our "young" PI teaching us how to pipette
Publications
Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways:
H3K27M-mutant diffuse midline glioma (DMG) patients have no proven effective therapies... Read Paper
Liquid biopsy in pediatric brain tumors:
Malignant primary brain tumors are the most common cancer in children aged 0–14 years ... Read Paper
Cell-Free Tumor DNA (cf-tDNA) Liquid Biopsy: Current Methods and Use in Brain Tumor Immunotherapy:
Gliomas are tumors derived from mutations in glial brain cells ... Read Paper
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma:
To our knowledge, we report the first demonstrated feasibility for serial CSF collection ... Read Paper
Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing:
Molecular markers are essential for cancer diagnosis ... Read Paper